Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinghong Shi

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Cancer Medicine|June 9, 2022
SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenanceJiafeng Chen, Zheng Gao, Xiaogang Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 29, 2025
Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors post-transplant: A prospective pilot trialYifeng He, Xiaowu Huang, Xiaoyong Huang, et al.
Frontiers in Oncology|August 18, 2023
Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6<sup>+</sup> CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinomaXiaogang Li, Zheng Gao, Jiafeng Chen, et al.
Cancer Science|June 2, 2026
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCAChengqiang Sun, Zheng Gao, Enfu Dong, et al.
Journal for Immunotherapy of Cancer|July 3, 2020
Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinomaFangming Liu, Weiren Liu, Shuang Zhou, et al.
Annals of Surgery|July 12, 2018
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 PatientsZheng Wang, Yuanfei Peng, Jingwu Hu, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 11, 2022
Attention-based Deep Learning for the Preoperative Differentiation of Axillary Lymph Node Metastasis in Breast Cancer on DCE-MRIJing Gao, Xin Zhong, Wenjuan Li, et al.
Experimental Cell Research|February 1, 2024
Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogrammingHan Wang, Fangming Liu, Xiaoling Wu, et al.
Clinical Epigenetics|August 23, 2025
Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinomaXuhui Zhao, Shengwei Mao, Yuan Fang, et al.
Clinics and Research in Hepatology and Gastroenterology|December 22, 2025
Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomyJialu Fu, Jiafeng Chen, Lei Jin, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Cancer Medicine|June 9, 2022
SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenanceJiafeng Chen, Zheng Gao, Xiaogang Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 29, 2025
Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors post-transplant: A prospective pilot trialYifeng He, Xiaowu Huang, Xiaoyong Huang, et al.
Frontiers in Oncology|August 18, 2023
Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6<sup>+</sup> CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinomaXiaogang Li, Zheng Gao, Jiafeng Chen, et al.
Cancer Science|June 2, 2026
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCAChengqiang Sun, Zheng Gao, Enfu Dong, et al.
Journal for Immunotherapy of Cancer|July 3, 2020
Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinomaFangming Liu, Weiren Liu, Shuang Zhou, et al.
Annals of Surgery|July 12, 2018
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 PatientsZheng Wang, Yuanfei Peng, Jingwu Hu, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 11, 2022
Attention-based Deep Learning for the Preoperative Differentiation of Axillary Lymph Node Metastasis in Breast Cancer on DCE-MRIJing Gao, Xin Zhong, Wenjuan Li, et al.
Experimental Cell Research|February 1, 2024
Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogrammingHan Wang, Fangming Liu, Xiaoling Wu, et al.
Clinical Epigenetics|August 23, 2025
Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinomaXuhui Zhao, Shengwei Mao, Yuan Fang, et al.
Clinics and Research in Hepatology and Gastroenterology|December 22, 2025
Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomyJialu Fu, Jiafeng Chen, Lei Jin, et al.
Pageof 13